Albemarle (ALB) Q2 Revenue Jumps
(NYSE:ALB), a leading producer of lithium and specialty chemicals, released its second quarter 2025 earnings on July 30, 2025. The headline: Albemarle outperformed analyst estimates on both GAAP revenue and non-GAAP EPS, even as persistent weakness in lithium prices pressured its key Energy Storage segment. Non-GAAP earnings per share were $0.11, well above the $(0.84) forecast, while GAAP revenue reached $1,330.0 million, beating the consensus estimate of $1,222.6 million. However, Both net sales and adjusted EBITDA (non-GAAP) declined compared to the prior-year period. The results show the effects of strong volumes, improved productivity, and tight cost control, against ongoing market headwinds.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Albemarle is a global leader in lithium production, supplying compounds essential for lithium-ion batteries powering electric vehicles (EVs) and renewable energy storage. Its business includes three core segments: Energy Storage (mainly lithium), Specialties (bromine and customized lithium solutions), and Ketjen (catalysts and refining chemicals).
Source Fool.com
Albemarle Corp Aktie
Die Albemarle Corp Aktie steht recht gut da: Mehr Buy- als Sell-Einschätzungen in der Community.
Trotz eines Kursziels von 65 €, das unter 161.14 € liegt, ergibt sich für Albemarle Corp ein negatives Potenzial von -59.66%.
